Publications

 

Stephen R. Walsh, M.D.

 

HIV Vaccine Development

Baden LR, SR Walsh, MS Seaman, RP Tucker, KH Krause, A Patel, JA Johnson, J Kleinjan, KE Yanosick, J Perry, P Abbink, L Peter, MJ Iampietro, A Cheung, MG Pau, M Weijtens, J Goudsmit, E Swann, M Wolff, H Loblein, R Dolin, and DH Barouch. First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus aerotype 26 HIV-1 Env vaccine (IPCAVD 001). J Infect Dis. 2013; 207(2):240-247. PMCID: PMC3532831

Barouch DH, J Liu, L Peter, PM Abbink, J Iampietro, A Cheung, G Alter, A Chung, A-S Dugast, N Frahm, MJ McElrath, H Wenschuh, U Reimer, MS Seaman, MG Pau, M Weijtens, J Goudsmit, SR Walsh, R Dolin, and LR Baden. Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001). J Infect Dis. 2013; 207(2):248-256. PMCID: PMC3532832

Baden LR, SR Walsh, MS Seaman, JA Johnson, RP Tucker, JA Kleinjan, JA Gothing, BA Engelson, BR Carey, A Oza, S Bajimaya, L Peter, C Bleckwehl, P Abbink, MG Pau, M Weijtens, M Kunchai, EM Swann, M Wolff, R Dolin, and DH Barouch. First-in-human evaluation of a hexon chimeric adenovirus vector expressing HIV-1 Env (IPCAVD 002). J Infect Dis. 2014;210(7):1052-1061. PMID: 24719474

Baden LR, Liu J, Li H, Johnson JA, Walsh SR, Kleinjan JA, Engelson BA, Peter L, Abbink P, Milner DA, Golden KL, Viani KL, Stachler MD, Chen BJ, Pau MG, Weijten M, Carey BR, Miller CA, Swann EM, Wolff M, Loblein H, Seaman MS, Dolin R, and Barouch DH. Induction of HIV-1-specific mucosal immune responses following intramuscular recombinant adenovirus serotype 26 HIV-1 vaccination of humans. J Infect Dis. 2015;211(4):518-528. PMID: 25165165

 

Smallpox Vaccine Improvement

Wilck MB, MS Seaman, LR Baden, SR Walsh, LE Grandpre, C Devoy, A Giri, JA Kleinjan, LC Noble, KE Stevenson, HT Kim, and R Dolin. Safety and immunogenicity of modified vaccinia Ankara (ACAM3000): Effect of dose and route of administration. J Infect Dis. 2010; 201(9): 1361-1370. PMCID: PMC3016847

Seaman MS, MB Wilck, LR Baden, SR Walsh, LE Grandpre, C Devoy, A Giri, LC Noble, JA Kleinjan, KE Stevenson, HT Kim, and R Dolin. Effect of immunization with modified vaccinia Ankara (ACAM3000) on subsequent challenge with Dryvax. J Infect Dis. 2010; 201(9): 1353-1360. PMCID: PMC3023456

Walsh SR, MS Seaman, LE Grandpre, C Charbonneau, KE Yanosick, B Metch, MC Keefer, R Dolin, LR Baden. Impact of anti-orthopoxvirus neutralizing antibodies induced by a heterologous prime-boost HIV-1 vaccine on insert-specific immune responses. Vaccine. 2012; 31(1): 114-119. PMCID: PMC3566524

Walsh SR, MB Wilck, DJ Dominguez, E Zablowsky, S Bajimaya, LS Gagne, KA Verrill, JA Kleinjan, A Patel, Y Zhang, H Hill, A Acharyya, DC Fisher, JH Antin, MS Seaman, R Dolin, and LR Baden. Safety and immunogenicity of modified vaccinia Ankara in hematopoietic stem cell transplant recipients: A randomized, controlled trial. J Infect Dis. 2013; 207(12): 1888-1897. PMCID: PMC3654753

 

Complete List of Published Work in MyBibliography:  

http://www.ncbi.nlm.nih.gov/sites/myncbi/stephen.walsh.1/bibliograpahy/40388797/public/?sort=date&direction=descending